The plant in Kabul, Afghanistan, is becoming a key contributor in the regional supply network for Abacavir Sulphate API. This local manufacturing potential represents a considerable step forward for the Afghan pharmaceutical industry and offers a distinct opportunity to reduce reliance on imports